Form 4: Sotera Health Executive Michael Rutz Reports Stock Transaction
SEC Form 4 Filing
Sotera Health's President of Sterigenics, Michael Rutz, reported a transaction involving the withholding of shares to cover tax obligations related to vested Restricted Stock Units.
Summary
- Michael Rutz, President of Sterigenics at Sotera Health, reported a transaction on November 20, 2024.
- The transaction involved the withholding of 2,889 shares of common stock to cover tax obligations related to the vesting of 6,521 Restricted Stock Units (RSUs).
- The shares were withheld at a price of $13.21 per share.
- Following the transaction, Mr. Rutz beneficially owns 541,520 shares of common stock, including 61,542 RSUs and 479,978 shares of common stock.
- Of the 479,978 shares, 425,115 are vested, and 54,863 remain subject to vesting conditions, vesting daily through May 13, 2025.
- The report also details previously granted stock options with various exercise prices and vesting schedules.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to executive stock transactions, which is neither positive nor negative. It is a neutral event from an investment perspective.
Industry Context
This is a routine filing related to executive compensation and is typical for publicly traded companies. It provides transparency into the stock ownership of key personnel.
Comparison to Industry Standards
- The vesting schedules and stock option grants are typical for executive compensation packages in publicly traded companies.
- The use of RSUs and stock options is a common practice to align executive interests with shareholder value.
- The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine tax withholding related to executive compensation.
- The filing provides transparency to stakeholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 11/20/2020 | Date of original RSU grant and filing of Power of Attorney for Mr. Rutz. |
| 03/02/2022 | Date of grant for stock options with a $20.03 exercise price. |
| 03/06/2023 | Date of grant for stock options with a $17.59 exercise price. |
| 03/04/2024 | Date of grant for stock options with a $14.59 exercise price. |
| 11/20/2024 | Date of the reported stock transaction. |
| 11/22/2024 | Date of signature for the Form 4 filing. |
| 05/13/2025 | Final vesting date for unvested common stock. |
Keywords
Sotera Health, Michael Rutz, Sterigenics, Stock Transaction, Restricted Stock Units, RSUs, Form 4, Insider Trading, Executive Compensation, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.